KP Tissue (KPT) reported Q4 FY2025 net income of CAD 2.6 million, reflecting CAD 2.8 million in its share of Kruger Products’ net income, a CAD 0.1 million dilution gain and CAD 0.3 million of depreciation tied to acquisition-related carrying value adjustments. For FY2025, KP Tissue posted net income of CAD 8.5 million, including CAD 9.2 million as its share of Kruger Products’ net income, a CAD 0.4 million dilution gain and CAD 1.1 million of related depreciation. At Kruger Products, Q4 FY2025 revenue rose 3.8% to CAD 560.1 million, while adjusted EBITDA increased 26.0% to CAD 84.2 million. Q4 net income was CAD 23.4 million versus a net loss a year earlier. For FY2025, revenue increased 7.5% to CAD 2.20 billion and adjusted EBITDA rose 20.2% to CAD 318.2 million, with net income of CAD 75.5 million. KP Tissue declared a quarterly dividend of CAD 0.18 per share, payable April 15, 2026, to shareholders of record March 31, 2026. Kruger Products said it is finalizing the location, scope and financial details of a new through-air-dried facility planned for the western U.S. in 2028, with an official announcement expected in H1 2026, and guided for Q1 2026 adjusted EBITDA to be in the range of Q4 FY2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KP Tissue Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9656497-en) on February 18, 2026, and is solely responsible for the information contained therein.